Stephen Franklin
No más puestos en curso
Historial de carrera de Stephen Franklin
Antiguos cargos conocidos de Stephen Franklin.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Evgen Ltd.
Evgen Ltd. Medical/Nursing ServicesHealth Services Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom. | Director/Miembro de la Junta | 01/01/2008 | 30/04/2020 |
Fundador | 01/01/2008 | 30/04/2020 | |
THERACRYF PLC | Director/Miembro de la Junta | 02/10/2014 | 30/04/2020 |
Director Ejecutivo | 02/10/2014 | 30/04/2020 | |
Fundador | 01/01/2007 | 30/04/2020 | |
Contacto de Relaciones con Inversores | - | - | |
PROVEXIS PLC | Director Ejecutivo | 01/09/2002 | 01/07/2007 |
Fundador | 01/09/2002 | 01/07/2007 | |
ANGLE PLC | Corporate Officer/Principal | 01/04/1998 | 01/09/2002 |
Manchester Biotech Ltd. | Corporate Officer/Principal | - | - |
Formación de Stephen Franklin.
The University of Nottingham | Masters Business Admin |
York University | Undergraduate Degree |
Estadísticas
Internacional
Reino Unido | 7 |
Canadá | 2 |
Operativa
Founder | 3 |
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Sectorial
Health Services | 3 |
Consumer Services | 3 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
PROVEXIS PLC | Health Technology |
ANGLE PLC | Distribution Services |
THERACRYF PLC | Health Services |
Empresas privadas | 2 |
---|---|
Evgen Ltd.
Evgen Ltd. Medical/Nursing ServicesHealth Services Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom. | Health Services |
Manchester Biotech Ltd. |
- Bolsa de valores
- Insiders
- Stephen Franklin
- Experiencia